Luye Pharma Group Ltd
Luye Pharma Group's GHG Emissions Data Preview
In 2023, Luye Pharma Group completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).
However, Luye Pharma Group has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2023 | 2022 | 2021 | 2020 - 2017 |
|---|---|---|---|---|
Total Scope 1 | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 3 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 1 Revenue Intensity (tCO2e/$M) | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data. | 0000000 |
Verified Sources Behind Luye Pharma Group’s Greenhouse Gas (GHG) Emissions Data
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Luye Pharma Group’s data sources below and access millions more through our Disclosure Search.
Insights into Luye Pharma Group's Operational Emissions
In 2023, the total operational greenhouse gas (GHG) emissions of Luye Pharma Group amounted to 76,201.353 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a
Compared to 2022, the total operational greenhouse gas (GHG) emissions of Luye Pharma Group decreased by 2.41%, showing that the company has made progress in taking action to reduce the climate impact of its operations. a
Luye Pharma Group's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are Luye Pharma Group's Scope 1 emissions?
In 2023, the total Scope 1 emissions of Luye Pharma Group were 10,755.273 metric tons of CO₂ equivalent (tCO₂e). a
Compared to the previous year (2022), Luye Pharma Group's Scope 1 emissions remained relatively stable, indicating that Luye Pharma Group's emissions have plateaued with no significant change in its operational footprint. a
What are Luye Pharma Group's Scope 2 emissions?
In 2023, Luye Pharma Group reported Scope 2 greenhouse gas (GHG) emissions of 65,446.08 tCO₂e without specifying the calculation method. a
Has Luye Pharma Group reduced its Scope 2 emissions over time?
Compared to the previous year (2022), Luye Pharma Group's Scope 2 emissions (Unspecified Calculation Method) have remained relatively stable, indicating that Luye Pharma Group 's emissions have plateaued with no significant change in its energy consumption footprint. a
What methodology does Luye Pharma Group use for Scope 2 reporting?
In 2023, Luye Pharma Group reported its Scope 2 emissions using an unspecified methodology. a
Luye Pharma Group's Scope 2 Emissions Over Time
- Total Scope 2 (Unspecified Calculation Method)
Insights into Luye Pharma Group’s GHG Emissions Intensity Compared to Industry Peers
In 2023, Luye Pharma Group reported Scope 1 greenhouse gas (GHG) emissions of 10,755.273 tCO₂e and total revenues of USD 945 millions. This translates into an emissions intensity of 11.38 tCO₂e per millions USD. a
Luye Pharma Group's Scope 1 Emissions Intensity Compared to Peers
How does Luye Pharma Group's GHG emissions intensity compare to its peers?
In 2023, Luye Pharma Group reported a Scope 1 emissions intensity of 11.38 tCO₂e per millions USD. Compared to the peer group median of 25.27 , this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors. a
Where does Luye Pharma Group rank on GHG emissions intensity within its industry?
In 2023, Luye Pharma Group ranked 10 out of 25 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a
Luye Pharma Group is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency. a